August 28, 2014 12:11 PM ET

Biotechnology

Company Overview of ScarX Therapeutics

Company Overview

ScarX Therapeutics, a pre-clinical stage biotechnology company, engages in the development of a therapeutic as the patient-administered prescription medication for the prophylaxis of dermal scarring in post-surgical wound closures. It develops MI-001 as an anti-scarring agent. The company is based in Toronto, Canada.

Toronto, ON 

Canada

Key Executives for ScarX Therapeutics

Chief Executive Officer
Chief Development Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

ScarX Therapeutics Key Developments

ScarX Therapeutics Presents at 12th Annual BIO Investor Forum, Oct-08-2013 10:00 AM

ScarX Therapeutics Presents at 12th Annual BIO Investor Forum, Oct-08-2013 10:00 AM. Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Similar Private Companies By Industry

Company Name Region
Agrisoma Biosciences Inc Americas
LifeLike BioTissue Inc. Americas
Generex Pharmaceuticals Inc. Americas
Coley Pharmaceutical Group, Ltd. Americas
Orcrist Bio Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ScarX Therapeutics, please visit www.scarxtherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.